Teva Pharmaceutical Industries Ltd
Close on Oct 19, 2026Market cap $48.13BP/E 68.9Yield –
Teva Pharmaceutical Industries Restructuring Liability Reserve by Quarter
Restructuring Liability Reserve — Ending Balance (Total) ($M)
Teva Pharmaceutical Industries Restructuring Liability Reserve: $114M in Q3 2026, down 32.1% from a year earlier.
Where the Q3 2026 figure comes from
Source: SEC Form 10-Q (0000818686-26-000006) ↗
Reported in SEC Form 10-K / Form 10-Q (XBRL & Footnotes).
quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
Breakdown
What makes up restructuring Liability Reserve
- Restructuring Reserve — Employee Termination Costs101 · Q3 2026
- Restructuring Reserve — Other Restructuring Costs13 · Q3 2026
- Restructuring Expense Recognized in Operations — Total58 · Q3 2026
- Restructuring Expense — Employee Termination57 · Q3 2026
- Restructuring Expense — Other Costs1 · Q3 2026
- Restructuring Reserve — Cash Payments & Utilization (Total)55 · Q3 2026
- Restructuring Reserve Utilization — Employee Termination53 · Q3 2026
- Restructuring Reserve Utilization — Other Costs2 · Q3 2026
Cite this data
StockData. (2026). Teva Pharmaceutical Industries Restructuring Liability Reserve ($M), quarterly Q4 2016–Q3 2026 [Data set]. Compiled from Teva Pharmaceutical Industries SEC filings and investor materials. https://stockdatahq.com/stocks/teva/kpis/restruct-res-total
See every metric in the Teva Pharmaceutical Industries KPI table. Data updated Nov 10, 2026.
See a number that looks wrong?